151 related articles for article (PubMed ID: 35633553)
21. Induction of apoptosis and bcl-2 expression in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma in children.
Pituch-Noworolska A; Hajto B; Balwierz W; Klus K
Haematologia (Budap); 2001; 31(3):191-207. PubMed ID: 11855781
[TBL] [Abstract][Full Text] [Related]
22. Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group.
Tsurusawa M; Saeki K; Katano N; Fujimoto T
Pediatr Hematol Oncol; 1998; 15(2):143-55. PubMed ID: 9592841
[TBL] [Abstract][Full Text] [Related]
23. HSP90 inhibition results in apoptosis of Philadelphia acute lymphoblastic leukaemia cells: an attractive prospect of new targeted agents.
Tavernier E; Flandrin-Gresta P; Solly F; Rigollet L; Cornillon J; Augeul-Meunier K; Stephan JL; Montmartin A; Viallet A; Guyotat D; Campos L
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1753-8. PubMed ID: 22706881
[TBL] [Abstract][Full Text] [Related]
24. Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia.
Findley HW; Gu L; Yeager AM; Zhou M
Blood; 1997 Apr; 89(8):2986-93. PubMed ID: 9108419
[TBL] [Abstract][Full Text] [Related]
25. In vitro determination of the apoptotic effect of heparin on lymphoblasts using DNA analysis and measurements of Fas and Bcl-2 proteins by flow cytometry.
Erduran E; Tekelioglu Y; Gedik Y; Bektaş I; Hacisalihoglu S
Pediatr Hematol Oncol; 2004; 21(5):383-91. PubMed ID: 15205081
[TBL] [Abstract][Full Text] [Related]
26. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
[TBL] [Abstract][Full Text] [Related]
27. Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh.
Wall NR; Mohammad RM; Al-Katib AM
Leuk Res; 1999 Oct; 23(10):881-8. PubMed ID: 10573132
[TBL] [Abstract][Full Text] [Related]
28. [Effects of acute lymphoblastic leukemia children bone marrow mesenchymal stem cells on drug resistance of K562/A02 cell line].
Wang ZX; Yang ZM; Zou YW; Li MM; Chen FX; Zhong GY; Guan JM; Wei FG; Wu SZ; He ZT; Wu ZL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):19-23. PubMed ID: 21362214
[TBL] [Abstract][Full Text] [Related]
29. The influence of Bcl-2 and myeloid antigen expression on response to therapy in childhood acute lymphoblastic leukemia.
Amirghofran Z; Daneshbod Y; Gholijani N; Esmaeilbeig M
Arch Iran Med; 2011 May; 14(3):170-4. PubMed ID: 21529104
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL).
Addeo R; Caraglia M; Baldi A; D'Angelo V; Casale F; Crisci S; Abbruzzese A; Vincenze B; Campioni M; Di Tullio MT; Indolfi P
Cancer Biol Ther; 2005 Jan; 4(1):32-8. PubMed ID: 15684603
[TBL] [Abstract][Full Text] [Related]
31. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
32. Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features.
Kaparou M; Choumerianou D; Perdikogianni C; Martimianaki G; Kalmanti M; Stiakaki E
Genet Mol Biol; 2013 Mar; 36(1):7-11. PubMed ID: 23569402
[TBL] [Abstract][Full Text] [Related]
33. High Bax/Bcl-2 ratio is associated with good prognosis and better survival in patients with B cell chronic lymphocytic leukemia.
Helaly NA; Esheba NE; Ammo DEA; Elwan NM; Elkholy RA
Leuk Res; 2021 Aug; 107():106604. PubMed ID: 33965850
[TBL] [Abstract][Full Text] [Related]
34. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
Kornblau SM; Vu HT; Ruvolo P; Estrov Z; O'Brien S; Cortes J; Kantarjian H; Andreeff M; May WS
Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
[TBL] [Abstract][Full Text] [Related]
35. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
36. Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
Park HS; Kim DY; Choi EJ; Lee JH; Lee JH; Jeon M; Kang YA; Lee YS; Seol M; Cho YU; Jang S; Chi HS; Lee KH; Park CJ
Acta Haematol; 2018; 139(4):220-227. PubMed ID: 29860259
[TBL] [Abstract][Full Text] [Related]
37. [Dynamic study of Bcl-2, Bax, p53, and ACE expression in CD34+ cells of peripheral blood and bone marrow in acute leukemia patients in the course of induction chemotherapy].
Khodunova EE; Parovichnikova EN; Gal'tseva IV; Kulikov SM; Isaev VG; Savchenko VG
Ter Arkh; 2011; 83(7):32-7. PubMed ID: 21894749
[TBL] [Abstract][Full Text] [Related]
38. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia.
Aref S; Salama O; Al-Tonbary Y; Mansour A
Hematology; 2004 Apr; 9(2):113-21. PubMed ID: 15203866
[TBL] [Abstract][Full Text] [Related]
39. Post chemotherapy blood and bone marrow regenerative changes in childhood acute lymphoblastic leukemia a prospective study.
Kushwaha R; Kumar A; Aggrawal K; Nigam N; Kumar A
Indian J Pathol Microbiol; 2014; 57(1):72-7. PubMed ID: 24739836
[TBL] [Abstract][Full Text] [Related]
40. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.
Kang MH; Kang YH; Szymanska B; Wilczynska-Kalak U; Sheard MA; Harned TM; Lock RB; Reynolds CP
Blood; 2007 Sep; 110(6):2057-66. PubMed ID: 17536015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
